These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2575103)

  • 1. Nosocomial gram-negative bloodstream isolates: a comparison of in vitro antibiotic potency.
    Stanley GL; Pfaller MA; Mori M; Wenzel RP
    J Hosp Infect; 1989 Oct; 14(3):217-25. PubMed ID: 2575103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections due to endemic, multiply resistant gram-negative rods: sensitivity to and therapy with cefoxitin.
    Alford RH
    Rev Infect Dis; 1979; 1(1):175-82. PubMed ID: 400932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro susceptibility of nosocomial gram-negative bloodstream pathogens to quinolones and other antibiotics--a statistical approach.
    Martin MA; Pfaller MA; Rojas PB; Woolson RF; Wenzel RP
    J Antimicrob Chemother; 1989 Mar; 23(3):353-61. PubMed ID: 2499564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on prevalence and molecular mechanisms of antibacterial resistance in Gram-negative pathogens of nosocomial infections in hospitals of Moscow and Perm'].
    Mudrak DE; Ikriannikova LN; Sidorenko SV; Il'ina EN
    Antibiot Khimioter; 2007; 52(7-8):10-6. PubMed ID: 18986019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of nosocomial pneumonia in infants after cardiac surgery.
    Tan L; Sun X; Zhu X; Zhang Z; Li J; Shu Q
    Chest; 2004 Feb; 125(2):410-7. PubMed ID: 14769717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of various antibiotic agents against gram-negative nosocomial bacteremia pathogens].
    Gür D; Kocagöz T; Akalin HE
    Mikrobiyol Bul; 1992 Jul; 26(3):233-41. PubMed ID: 1528143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
    Doebbeling BN; Pfaller MA; Bale MJ; Wenzel RP
    Eur J Clin Microbiol Infect Dis; 1990 Apr; 9(4):298-301. PubMed ID: 2112467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of levofloxacin against recent Gram-negative nosocomial pathogens.
    Lanzafame A; Bonfiglio G; Santini L; Mattina R
    Chemotherapy; 2005 Mar; 51(1):44-50. PubMed ID: 15767745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Broad-spectrum beta-lactamases. Clinical significance and detection methods].
    Sidorenko SV
    Antibiot Khimioter; 2001; 46(12):27-34. PubMed ID: 12108090
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in-vitro study on ciprofloxacin and other anti-microbials against gram-negative bacteria isolated from patients in Ibadan, Nigeria.
    Rotowa NA; Montefiore D; Adeyemi-Doro FA
    Afr J Med Med Sci; 1989 Mar; 18(1):63-7. PubMed ID: 2545087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary infection. I. Comparative in vitro activities of several antibiotic drugs against Gram-negative bacteria].
    Giachino F; Allocco A; Tuninetti L; Tullio V; Cuffini AM; Carlone NA
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):55-67. PubMed ID: 7498617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007).
    Patzer JA; Dzierzanowska D; Turner PJ
    J Antimicrob Chemother; 2008 Aug; 62(2):369-75. PubMed ID: 18445575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins.
    Dworzack DL; Pugsley MP; Sanders CC; Horowitz EA
    Eur J Clin Microbiol; 1987 Aug; 6(4):456-9. PubMed ID: 3499316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects on beta-lactam susceptibility of phenotypic induction and genotypic derepression of beta-lactamase synthesis.
    Shannon K; Phillips I
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():15-22. PubMed ID: 3102451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection - bacteria and their synergistic potential with antibiotics.
    Fadli M; Saad A; Sayadi S; Chevalier J; Mezrioui NE; Pagès JM; Hassani L
    Phytomedicine; 2012 Mar; 19(5):464-71. PubMed ID: 22257599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance pattern of gram-negative bacteria of nosocomial origin at a teaching hospital in the Islamic Republic of Iran.
    Khalili H; Soltani R; Safhami S; Dashti-Khavidaki S; Alijani B
    East Mediterr Health J; 2012 Feb; 18(2):172-7. PubMed ID: 22571095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance. Nosocomial gram-negative infection.
    Gransden WR
    J Med Microbiol; 1997 Jun; 46(6):436-9. PubMed ID: 9379467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.